Back to Results

Caliber Imaging & Diagnostics Inc (LCDX)

Caliber Imaging & Diagnostics, Inc. is a healthcare technology company focused on imaging solutions that visualize tissue at the cellular level. The company develops and markets products used in the United States by clinicians and researchers, including the VivaScope 1500 confocal imaging system, which is designed to capture images of cellular structures in living tissue, and the VivaScope 3000, a handheld in vivo reflectance confocal microscope for skin imaging. Its software and digital tools include VivaScan, which supports patient scheduling, examination workflow, image review, and reporting, as well as VivaNet, a digital telepathology system. The company, previously known as Lucid, Inc., adopted its current name in August 2012. Founded in 1991, Caliber Imaging & Diagnostics is headquartered in Andover, Massachusetts, and its common stock trades on OTC Markets under the symbol LCDX.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-LCDX
Not available
Not available
Not available
Good
0.0%
5.22 K
Valuation • Fair Value

Caliber Imaging & Diagnostics Inc (OTC-LCDX) Fair Value by Valuation Model

No usable valuation estimate is currently available for Caliber Imaging & Diagnostics Inc (OTC-LCDX); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Caliber Imaging & Diagnostics Inc (OTC-LCDX). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Caliber Imaging & Diagnostics Inc (OTC-LCDX)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Caliber Imaging & Diagnostics Inc (OTC-LCDX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Caliber Imaging & Diagnostics Inc (OTC-LCDX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Caliber Imaging & Diagnostics Inc (OTC-LCDX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Caliber Imaging & Diagnostics Inc (OTC-LCDX)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Caliber Imaging & Diagnostics Inc (OTC-LCDX). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Caliber Imaging & Diagnostics Inc (OTC-LCDX) Stock FAQ

Data-supported answers about Caliber Imaging & Diagnostics Inc (OTC-LCDX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for Caliber Imaging & Diagnostics Inc (OTC-LCDX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Caliber Imaging & Diagnostics Inc (OTC-LCDX) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Caliber Imaging & Diagnostics Inc (OTC-LCDX).

The current market capitalization listed for Caliber Imaging & Diagnostics Inc is 5.22 K.

The ticker symbol for Caliber Imaging & Diagnostics Inc is OTC-LCDX, and the stock is listed on OTC Markets.

Caliber Imaging & Diagnostics Inc (OTC-LCDX) is listed on OTC Markets.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 177.6 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 139 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 117.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 62.81 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 50.873 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.286 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 41.807 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 40.289 B
DXCM NASDAQ DexCom Inc Fair Value Fair Market Cap 33.717 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 32.188 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.559 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 28.967 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.25 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 19.991 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 18.189 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.123 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.51 B
BAX NYSE Baxter International Inc Fair Value Undervalued Market Cap 11.788 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.577 B